I am writing today to announce the closure of the Michigan Messenger. After four years of operation in Michigan, the board of the American Independent News Network, has decided to shift publication of its news into a single site, The American Independent at Americanindependent.com. This is part of a shift in strategy, towards new forms [...]
An abstinence-only presentation provided to numerous school districts in Calhoun and Eaton Counties in October of this year provided false and misleading information to students about HIV, experts allege.
Two county registers of deeds filed a class action lawsuit Monday on behalf of Michigan’s 83 counties alleging that the Mortgage Electronic Registration Services owes millions of dollars in property title transfer taxes.
Despite evidence of the impact of mercury on children and public health, Michigan Attorney General Bill Schuette last month joined with 24 other state attorneys general in filing a lawsuit to scuttle new EPA regulations that would reduce mercury emissions from power plants.
A new University of Michigan study has found that administering the human papillomavirus vaccine based on a woman’s risk factors could keep the vast majority of eligible women from getting the cancer-fighting vaccine.
The results support a federal recommendation that all females ages 11 to 26 should get the vaccine, the study’s lead researcher said.
The study finds that using risk factors including sexual history would not only exclude about 80 percent of eligible women but also would likely vaccinate a large number of women already infected with at least one of the four HPV strains the vaccination helps protect against.
Continued -“We found that the more risk factors a woman had, the more likely they were infected with one of the four strains of HPV, but we couldn’t find a specific threshold of risk factors that would predict which women would have HPV and which wouldn’t,” said lead researcher Dr. Amanda Dempsey.
“What we found was whether you used risk factors or didn’t, either was very poor for selecting women who were at risk for HPV,” she added. “There’s really no way to use risk factors to sort out women into who would or wouldn’t benefit from the vaccine.”
The study was published Wednesday in the journal Vaccine by researchers at U of M’s C.S. Mott Children’s Hospital’s Child Health Evaluation and Research Unit.
The study was an attempt to address issues raised by the vaccine’s high cost and conflicting recommendations for which patients should be vaccinated.
The American Cancer Society advocates vaccinating all females younger than 18, and selectively vaccinating women ages 19 to 26 based on a discussion between the patient and her doctor about her sexual history. However, the U.S. Centers for Disease Control and Prevention’s Advisory Committee on Immunizations Practices recommends universal vaccination for all females ages 11 to 26, regardless of sexual experience.
The HPV vaccine is the most expensive routinely recommended vaccine and is not fully covered by all insurance plans or by state and federal financing. So researchers set out to see if there was a way to target its use based on a woman’s risk factors for contracting the virus, Dempsey said.
“It’s very exciting for people in medicine because now there’s a way you can potentially prevent cancer through vaccination,” Dempsey said. “That’s the positive side. On the less exciting side is
Do you know where to vote on Election Day? Do you know what to bring with you? Get comprehensive voter information for your state here.
Sign up for our email newsletter